Cargando…
Successful direct acting antiviral (DAA) treatment of HCV/HIV-coinfected patients before and after liver transplantation
OBJECTIVES: The aim of this multicenter retrospective study was to investigate safety and efficacy of direct acting antiviral (DAA) treatment in the rare subgroup of patients with HCV/HIV-coinfection and advanced liver cirrhosis on the liver transplant waiting list or after liver transplantation, re...
Autores principales: | Grottenthaler, Julia M., Werner, Christoph R., Steurer, Martina, Spengler, Ulrich, Berg, Thomas, Engelmann, Cornelius, Wedemeyer, Heiner, von Hahn, Thomas, Stremmel, Wolfgang, Pathil, Anita, Seybold, Ulrich, Schott, Eckart, Blessin, Usha, Sarrazin, Christoph, Welker, Martin-Walter, Harrer, Ellen, Scholten, Stefan, Hinterleitner, Clemens, Lauer, Ulrich M., Malek, Nisar P., Berg, Christoph P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5991346/ https://www.ncbi.nlm.nih.gov/pubmed/29874250 http://dx.doi.org/10.1371/journal.pone.0197544 |
Ejemplares similares
-
Platelet-Expressed Synaptophysin (pSyn) as Novel Biomarker in Neuroendocrine Malignancies
por: Hinterleitner, Martina, et al.
Publicado: (2021) -
Feasibility of Telaprevir-Based Triple Therapy in Liver Transplant Patients with Hepatitis C Virus: SVR 24 Results
por: Werner, Christoph R., et al.
Publicado: (2013) -
First-generation protease inhibitor-triple therapy: SVR 24, safety, and predictors of response in a large single center cohort
por: Werner, Christoph R, et al.
Publicado: (2015) -
Second-generation direct-acting-antiviral hepatitis C virus treatment: Efficacy, safety, and predictors of SVR12
por: Werner, Christoph R, et al.
Publicado: (2016) -
Antibodies to the Muscarinic Acetylcholine Receptor M3 in Primary Biliary Cholangitis Inhibit Receptor Function on Cholangiocytes
por: Mayer, Christian, et al.
Publicado: (2020)